Literature DB >> 21299831

A description of the costs of living and standard criteria deceased donor kidney transplantation.

L Barnieh1, B J Manns, S Klarenbach, K McLaughlin, S Yilmaz, B R Hemmelgarn.   

Abstract

Kidney transplantation improves quality of life and survival and is associated with lower health care costs compared with dialysis. We described and compared the costs of living and standard criteria for deceased donor kidney transplantation. Patients included adult recipients of a first kidney-only transplant between April 1, 1998, and March 31, 2006, as well as their donor information. All costs (outpatient care, diagnostic imaging, inpatient care, physician claims, laboratory tests and transplant medications) for 2 years after transplant for recipients and transplant-related costs prior to transplant (donor workup and management) were included. Complete cost information was available for 357 recipients. The mean total 2-year cost of transplantation, including donor costs, for recipients of living and deceased donors was $118 347 (95% confidence interval [CI], 110 395-126 299) and $121 121 (95% CI 114 287-127 956), respectively (p = 0.7). The mean cost for a living donor was $18 129 (95% CI 16 845-19 414) and for a deceased donor was $36 989 (95% CI 34 421-39 558). Living donor kidney transplantation has similar costs at 2 years compared with deceased donor transplantation. These results can be used by health care decision makers to inform strategies to increase donation. ©2011 The Authors Journal compilation©2011 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Year:  2011        PMID: 21299831     DOI: 10.1111/j.1600-6143.2010.03425.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  16 in total

1.  Adding specialized clinics for remote-dwellers with chronic kidney disease: a cost-utility analysis.

Authors:  Natasha Wiebe; Scott W Klarenbach; Betty Chui; Bharati Ayyalasomayajula; Brenda R Hemmelgarn; Kailash Jindal; Braden Manns; Marcello Tonelli
Journal:  Clin J Am Soc Nephrol       Date:  2011-11-10       Impact factor: 8.237

Review 2.  Economic evaluation of dialysis therapies.

Authors:  Scott W Klarenbach; Marcello Tonelli; Betty Chui; Braden J Manns
Journal:  Nat Rev Nephrol       Date:  2014-08-26       Impact factor: 28.314

3.  Medical students faced with related and unrelated living kidney donation: a stratified and multicentre study in Spain.

Authors:  A Ríos; A López-Navas; A López-López; F J Gómez; J Iriarte; R Herruzo; G Blanco; F J Llorca; A Asunsolo; P Sánchez; P R Gutiérrez; A Fernández; M T de Jesús; L Martínez-Alarcón; M Del Olivo; L Fuentes; J R Hernández; J Virseda; J Yelamos; J A Bondía; A Hernández; M A Ayala; P Ramírez; P Parrilla
Journal:  World J Urol       Date:  2016-02-27       Impact factor: 4.226

4.  Clinical and genetic factors affecting tacrolimus trough levels and drug-related outcomes in Korean kidney transplant recipients.

Authors:  In-Wha Kim; Yoo Jin Moon; Eunhee Ji; Kyung Im Kim; Nayoung Han; Sung Ju Kim; Wan Gyoon Shin; Jongwon Ha; Jeong-Hyun Yoon; Hye Suk Lee; Jung Mi Oh
Journal:  Eur J Clin Pharmacol       Date:  2011-12-20       Impact factor: 2.953

5.  The cost-effectiveness of using payment to increase living donor kidneys for transplantation.

Authors:  Lianne Barnieh; John S Gill; Scott Klarenbach; Braden J Manns
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-24       Impact factor: 8.237

6.  Economic evaluation of frequent home nocturnal hemodialysis based on a randomized controlled trial.

Authors:  Scott Klarenbach; Marcello Tonelli; Robert Pauly; Michael Walsh; Bruce Culleton; Helen So; Brenda Hemmelgarn; Braden Manns
Journal:  J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 10.121

7.  A comprehensive approach to assess the costs of renal replacement therapy for end-stage renal disease in France: the importance of age, diabetes status, and clinical events.

Authors:  Anne-Line Couillerot-Peyrondet; Cléa Sambuc; Yoël Sainsaulieu; Cécile Couchoud; Isabelle Bongiovanni-Delarozière
Journal:  Eur J Health Econ       Date:  2016-05-05

8.  Population level outcomes and cost-effectiveness of hepatitis C treatment pre- vs postkidney transplantation.

Authors:  Brittany A Shelton; Deirdre Sawinski; Benjamin P Linas; Peter P Reese; Margaux Mustian; Mitch Hungerpiller; Rhiannon D Reed; Paul A MacLennan; Jayme E Locke
Journal:  Am J Transplant       Date:  2018-08-30       Impact factor: 9.369

9.  Projecting prevalence, costs and evaluating simulated interventions for diabetic end stage renal disease in a Canadian population of aboriginal and non-aboriginal people: an agent based approach.

Authors:  Amy Gao; Nathaniel D Osgood; Ying Jiang; Roland F Dyck
Journal:  BMC Nephrol       Date:  2017-09-04       Impact factor: 2.388

10.  Has the UK living kidney donor population changed over time? A cross-sectional descriptive analysis of the UK living donor registry between 2006 and 2017.

Authors:  Phillippa K Bailey; Katie Wong; Matthew Robb; Lisa Burnapp; Alistair Rogers; Aisling Courtney; Caroline Wroe
Journal:  BMJ Open       Date:  2020-06-15       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.